1. Home
  2. PL vs AXSM Comparison

PL vs AXSM Comparison

Compare PL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$41.29

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$227.21

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
AXSM
Founded
2010
2012
Country
United States
United States
Employees
970
925
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
12.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PL
AXSM
Price
$41.29
$227.21
Analyst Decision
Buy
Strong Buy
Analyst Count
12
17
Target Price
$27.64
$211.12
AVG Volume (30 Days)
7.8M
849.8K
Earning Date
06-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.29
$57.24
Revenue Next Year
$30.22
$55.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.47
$96.09
52 Week High
$43.31
$235.92

Technical Indicators

Market Signals
Indicator
PL
AXSM
Relative Strength Index (RSI) 57.77 68.50
Support Level $32.23 $148.87
Resistance Level $41.71 $234.29
Average True Range (ATR) 3.73 10.61
MACD 0.21 0.84
Stochastic Oscillator 65.91 83.59

Price Performance

Historical Comparison
PL
AXSM

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: